Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Recruiting

Phase 2

Brain CancerIdentifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Sponsor:

ECOG-ACRIN Cancer Research Group

Code:

NCT06319027

Conditions

Glioblastoma, IDH-Wildtype

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging

Fluciclovine F18

Gadolinium-Chelate

Magnetic Resonance Spectroscopy

Positron Emission Tomography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-05. This information was provided to ClinicalTrials.gov by ECOG-ACRIN Cancer Research Group on 2025-09-25.